Yes the whole article in today's Australian (p1&8)is quite an extensive coverage and best of all confirms that the phase 2b trials seem to be working with longer remissions(usually the remission period when chemo only is used becomes shorter with time) and no side effects reported by the patient interviewed.
It also mentions that "to date the CVAC has been well tolerated and a few patients in the final stages of the disease who were expected to live for only a few months ------ had survived for three or four years------".
Looks like Greenslopes Hospital Brisbane will be up and running for phase 3 in the very near future.
"Neil Frazer was hopeful of even better outcomes in the phase 3 trial which will involve women recently diagnosed with stage 3 or 4 cancer."
I recommend that people read the whole article and congratulate the company (MR?) for getting front page coverage plus more (and a large colour photo!)in one of the most popular national papers-the Australian.This should help with exposure to the US market in the months to come!
cheers
Birdseye
frazer brother's new 'gift' for cancer suff..., page-5
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
-0.015(4.23%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 35.0¢ | 35.8¢ | 33.5¢ | $1.374M | 3.957M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 95461 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 48512 | 1 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |